SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form S-3ASR - Automatic shelf registration statement of securities of well-known seasoned issuers:
SEC Accession No. 0001193125-23-173898
Filing Date
2023-06-23
Accepted
2023-06-23 16:48:27
Documents
6
Effectiveness Date
2023-06-23

Document Format Files

Seq Description Document Type Size
1 S-3ASR d456683ds3asr.htm S-3ASR 134780
2 EX-5.1 d456683dex51.htm EX-5.1 7794
3 EX-23.1 d456683dex231.htm EX-23.1 1743
4 EX-FILING FEES d456683dexfilingfees.htm EX-FILING FEES 27440
5 GRAPHIC g456683dsp1.jpg GRAPHIC 3067
6 GRAPHIC g456683g01a03.jpg GRAPHIC 62980
  Complete submission text file 0001193125-23-173898.txt   264245
Mailing Address 7575 GATEWAY BOULEVARD SUITE 110 NEWARK CA 94560
Business Address 7575 GATEWAY BOULEVARD SUITE 110 NEWARK CA 94560 510-293-8800
CymaBay Therapeutics, Inc. (Filer) CIK: 0001042074 (see all company filings)

IRS No.: 943103561 | State of Incorp.: DE | Fiscal Year End: 1231
Type: S-3ASR | Act: 33 | File No.: 333-272893 | Film No.: 231038399
SIC: 2834 Pharmaceutical Preparations